Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Agatolimod + Trastuzumab in Metastatic Breast Cancer
NCT00824733Phase 2Terminated
- Sponsor
- Bhuvaneswari Ramaswamy
- Start
- Feb 2009
- Primary completion
- Feb 2013
- Modality
- Antisense DNA, Small Interfering RNA (siRNA), MicroRNA (miRNA)
- Countries
- 1
01
Overview
A Phase 2 trial of agatolimod in breast cancer, sponsored by Bhuvaneswari Ramaswamy. Started Feb 2009; status: terminated.
02
Drugs
agatolimod
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00824733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00824733.